Al-Dawaa Medical Services Company (4163.SR)

SAR 78.9

(-0.63%)

Market Cap (In SAR)

6.7 Billion

Revenue (In SAR)

5.74 Billion

Net Income (In SAR)

329.22 Million

Avg. Volume

221.92 Thousand

Currency
SAR
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.0-121.6
PE
-
EPS
-
Beta Value
0.058
ISIN
SA15H14I11H6
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Mohammed Saad Butti Alfarraj
Employee Count
-
Website
https://www.al-dawaa.com.sa
Ipo Date
2022-03-16
Details
Al-Dawaa Medical Services Company operates as a pharmaceutical retail company in the Kingdom of Saudi Arabia. The company operates through Retail and Wholesale segments. It offers medicines, perfumes, beauty tools and products, cosmetics, and other pharmaceutical products. The company is also involved in pharmacy activities, pharmaceutical warehouse activities, retailing of medical equipment, land transport of goods, managing and renting self-storage stores, and provision of marketing services on behalf of third parties, as well as acting as a pharmaceutical agent. It operates through a network of 837 pharmacies. In addition, the company sells its pharmaceutical products through online and wholesale channels. Al-Dawaa Medical Services Company was founded in 1991 and is based in Al Khobar, the Kingdom of Saudi Arabia.